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(ICI79939)3.4 they could shorten the dies-
tral period of mares. An I. U. or I. M. in-
jection of 230 ugm given during the fourth 
to thirteenth day of diestrus for two days 
brought the mares into estrus in three 
days, and ovulation occurred in seven to 
twelve days peaking at ten days. If given 
before three days old, the CL is not suscep-
tible. 
There are many clinical possibilities for 
the use of prostaglandins in the mare. 
Using prostaglandins, one could control 
and shorten the cycle of the mare by de-
creasing the time spent in diestrus. They 
could be of particular importance on the 
breeding farm where many mares are 
booked to one stallion so that the estrus 
periods could be planned to prevent con-
current estrus periods. Where A. I. is prac-
ticed prostaglandins would prove invalu-
able. In Thoroughbred mares whose breed-
ing season is restricted and A. I. not allow-
ed by the breed registration authorities 
prostaglandins could shorten estral cycles 
from 22 to 14 days,:! thus increasing the 
number of possible cycles per season. As 
a final touch, they provide a means of 
treating the "problem mare" with a per-
sistant CL which prevents normal cycling. 
This category could include early abortion, 
resorption, barren or lactating mares. 
Although the main emphasis in re-
search has been on reproduction, prosta-
glandins show promise in various other 
areas of research relating to man and 
animals. 1 
ULCERS-Certain prostaglandins decrease 
gastric acid secretion in the dog, pos-
sibly relating to peptic ulcers in man. 
HYPERTENSION - The A and E groups 
decrease blood pressure by dilating 
peripheral vessels, while PGF types 
increase blood pressure. 
KIDNEY DISEASE-PGF1 , PGF2 , and 
PGA, effect the kidney causing an in-
creased renal blood flow, urine vol-
ume and sodium excretion. Possibly 
congenital heart disease and kidney 
failure are related to a lack of natural 
PGF 2 production. 
THROMBI-PGE1 inhibits thombus forma-
tion while PGF 2 stimulates it. 
RESPIRATORY DISEASE - PGE1 and 
PGF2 relax the smooth muscle of 
bronchioles in animals and man. It 
has been shown to be a more potent 
bronchiodilator than isoproterenal. 
Prostaglandins have also been impli-
cated as causes of various pathological 
conditions, including glaucoma, tumors 
and inflammation. The research informa-
tion increases daily and the day is near 
that we will have prostaglandins as thera-
peutic' agents. Only time will tell if they 
will live up to their expectations. 
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Drug Interactions 
by 
Gary A. Eckhoff. D.V.M., M.S.* 
Rapid advances in research in basic 
pharmacology and the productivity of the 
pharmaceutical industry have resulted in 
the introduction of many new drugs for 
• Dr. Eckhoff is an Instructor of Pharmacology in the 
Department of Veterinary Physiology and Pharmacology, 
Iowa State University College of Veterinary Medicine. 
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the veterinary profession. The availability 
of large numbers of drugs has stimulated 
their concomitant use with the hope that 
maximum therapeutic effectiveness will 
be achieved. Indeed modern therapeutics 
in veterinary medicine often necessitates 
the simultaneous administration of several 
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drugs. With the increased use of multiple 
drug therapy has come the problem of 
drug interactions which necessitates 
greater professional awareness and re-
sponsibility on the part of the veterin-
arian. 
Recent studies indicate that hospitalized 
patients in human medicine receive an av-
erage of 14 different drugs during a typical 
stay in the hospita1.2 It has also been 
shown that drug reactions increase geo-
metrically as the number of drugs admin-
istered increases.s Even though the aver-
age number of drugs administered to hos-
pitalized animals has not been reported, 
drug interactions are certainly of great im-
portance to the veterinary practitioner. 
Drug interaction in its narrowest sense 
refers to the reaction between two or more 
thereapeutic agents administered concur-
rently or in close sequence which results 
in an altered response of one or more 
drugs. Thus the expected effect. of each 
agent administered may be increased or 
diminished or a new or toxic reaction may 
occur. This definition must be expanded 
to include an interplay between drugs and 
other exogenous chemical agents-food, 
feed additives, environmental pollutants, 
insecticides, and pesticides. 
A particularly important potential inter-
action exists betwen prescription and non-
prescription drugs. Non-prescription drugs 
are freely available to the public without 
professional control from a variety of out-
lets. It is thus advisable for the veterina-
rian to inquire about possible previous 
medication on the part of the animal 
owner. 
An equally important consideration is 
the prevention of drug residues in meat 
and milk. It is well to remember that with-
drawal times may change as a result of in-
teraction in the animal body when two or 
more drugs are used together. 
Although the untherapeutic and adverse 
consequences of drug interactions are em-
phasized in this paper, the beneficial side 
of drug interaction should be made ap-
parent. It is often noted that today's side 
effect may be tomorrow's therapeutic ef-
fect. A well known beneficial drug inter-
action exists in the kidney between pro-
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benecid and penicillin. Both of these 
agents compete for the same renal tubular 
organic acid transport system with result-
ing longer therapeutic blood levels of peni-
cillin. Phenobarbital, one of the most 
powerful inducers of nonspecific hepatic 
drug metabolizing enzymes, is used in the 
dairy cow which has ingested ample quan-
tities of chlorinated hydro-carbons. The ex-
tremely lipid soluble nature of these 
agents results in a lengthy milk discard 
time on the part of the dairy farmer. When 
a daily series of phenobarbital injections is 
given, the chlorinated hydrocrabon is 
more rapidly removed from the body 
through enhancement of hepatic drug-
metabolizing enzymes. From these ex-
amples it is apparent that drug interac-
tions, once recognized, understood, and 
controlled may become therapeutically 
beneficial. 
Since the list of known drug interac-
tions is too overwhelmingly long to commit 
to memory (one such tabulation lists 1300 
interactions),7 it is important that the 
practicing veterinarian have a basic un-
derstanding of the mechanisms by which 
interactions may develop. Such an under-
standing will aid in anticipating and man-
aging drug interactions when they do oc-
cur. 
Several excellent discussions of the 
mechanisms of drug interaction have re-
cently been published for the medical 
practitioner.1•6,5,3,4 Many of these contain 
numerous listings of interactions. 
Modifications of drug response due to 
drug interaction may occur at any site of 
drug passage through the body, e.g., ad-
ministration, absorption, distribution, re-
ceptor site, metabolism, and excretion. 
Direct Drug Interactions 
Direct interactions result from chemical 
or physical incompatibility or inactivation 
and may occur in vitro or in vivo. For ex-
ample many acidic drugs interact directly 
with basic drugs. In many cases in vitro 
interaction results in the precipitation of 
one or both agents. A vivid demonstration 
of this is simultaneous mixing in one 
syringe of a local anesthetic such as lido-
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caine with a barbiturate anesthetic such 
as sodium pentobarbital. Most incompati-
bilities in practice arise from placing two 
or more drugs in the same syringe or LV. 
fluid bottle. An in vivo illustration is the 
treatment of excessive anticoagulation due 
to heparin, an acid drug, with the intra-
venous use of protamine, a strong base. 
Interactions Affecting Drug Absorption 
Since a large number of drugs are ad-
ministered orally, most drug interactions 
altering absorption occur in the gastroin-
testinal tract. Interactions may not only 
increase or decrease the relative rate of 
absorption, but also may increase or de-
crease total bioavailability of drugs. Condi-
tions responsible for altered availability 
can be pH changes, physical or chemical 
binding of two or more drugs, and altera-
tions in mobility and contents of the gut. 
The great majority of drugs are passive-
ly transported across the lipid containing 
membrane of cells lining the gastrointes-
tinal tract. A basic principle of pharma-
cology is that drugs, being weak acids or 
bases, are more readily absorbed in the 
unionized form than the ionized form. In-
traluminal pH changes brought on by one 
drug can influence the amount of union-
ized form and thus the amount of another 
drug which is absorbed. It would be ex-
pected that antacids would diminish the 
rate of absorption of acidic drugs such as 
sulfonamides, phenylbutazone, nitrofuran-
toin, aspirin, and phenobarbital. 
Complexation reactions within the GI 
tract may significantly lower absorption. 
Tetracyclines can combine with polyvalent 
ions such as calcium, magnesium, alumi-
num and iron to form complexes which 
are poorly absorbed. Milk products and 
certain antacids can significantly reduce 
the absorption of this class of antibiotics. 
Antidiarrheal combinations are capable 
of adsorbing drugs administered concur-
rently. For example, a kaolin-pectin mix-
ture can produce erratic absorption of lin-
comycin when the two are given simul-
taneously. 
It is also recognized that antibiotics are 
capable of enhancing the anticoagulant 
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action of the coumarins by reducing vita-
min K synthesizing bacterial flora in the 
intestine. 
Interactions Affecting Drug Metabolism 
(Biotransformation) 
The principle site of drug metabolism, 
usually to inactive ionized metabolites, is 
the smooth endoplasmic reticulum (mi-
crosmal enzyme fraction) of liver cells. 
This system is rather non-specific and can 
handle most drugs and other exogenous 
compounds. The clinical significance of 
metabolism is that polar metabolites are 
more readily excreted. 
Animal studies in recent years have 
shown that many drugs and other foreign 
agents have the capability of increasing or 
decreasing the rate of metabolism of other 
drugs or foreign compounds. Virtually all 
pharmacological classes of drugs used in 
veterinary medicine contain numerous ex-
amples of this type of interaction. En-
hanced metabolism is brought on by "en-
zyme induction" whereby liver cells are 
stimulated by a drug to syntheSize greater 
quantities. of microsomal metabolizing 
enzyme protein. The clinical significance 
is that when a second drug is administered 
it may be metabolized rapidly resulting in 
minimum therapeutic effect. The me-
chanism of drug interaction due to in-
hibited drug metabolism is less under-
stood. An explanation may be competitive 
inhibition at the same site on metaboliz-
ing liver enzymes. 
Interactions Affecting Renal Excretion 
The urine constitutes the major route of 
excretion of unmetabolized drugs. Alkaline 
urine increases the ionization of acidic 
drugs, thereby reducing drug reabsorption 
from the nephron. Sodium bicarbonate ac-
celerates the excretion of phenobarbital 
and salicylate which can be of clinical sig-
nificance following overdosage of these 
two drugs. In a: similar way acidification 
of the urine by ammonium chloride in-
creases the excretion of weak bases. 
Some drugs are actively secreted into 
the urine rather than passively excreted. 
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Competition of two or more drugs for ac-
tive transport systems represents another 
major type of drug interaction. Decreased 
excretion rates of penicillin and oxphenyl-
butazone when given together are ex-
plained by this mechanism. 
Interactions Affecting Drug Distribution 
Many drugs become reversibly bound to 
plasma and tissue proteins. When bound 
they are pharmacologically inactive. Cer-
tain drugs may compete for the same 
binding sites on the plasma proteins. Clin-
ically significant responses may result 
when the unbound level (active form) is 
increased by displacing it from its bind-
ing sites with a second drug. Displace-
ment of sulfonamides by drugs such as 
phenylbutazone will greatly increase sul-
fonamide tissue concentration with pos-
sible toxic results. 
Interaction at the Site of Action 
The pharmacological effect of one drug 
may be modified at the site of action by 
another drug through competition for the 
receptor site, alteration of the receptor site 
or specific components and effects on a 
different biological system which has sim-
ilar or opposite effects. In veterinary medi-
cine documented examples of adverse 
drug interactions at this site are uncom-
mono A well known beneficial interaction 
is the use of atropine in the therapeutic 
management of excessive endogenous 
acetylcholine resulting from organic 
phosphate toxicity. 
Conclusion 
The mechanisms of drug interactions 
have been discussed. Predispositions for 
adverse drug interactions certainly exist 
in veterinary medicine today and may in 
large part be responsible for adverse drug 
reactions in general, including lack of 
efficacy. Prevention and management of 
adverse drug interactions in veterinary 
medical practice clearly dictates continu-
ing education in clinical pharmacology 
of the potent therapeutic agents available 
to veterinarians today. 
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Collection Development for the 
New Veterinary Medical 
College Library 
by 
Sally Peterson * 
The Iowa State University Veterinary 
Medical Library was the recipient this past 
year of an $83,000 grant awarded to aid 
in providing library materials for the new 
veterinary medical college complex now 
• Mrs. Peterson is the Veterinary Medical Librarian at 
Iowa State University. 
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under construction approximately two 
miles from the central campus. The N a-
tional Library of Medicine resource project 
grant funded by the National Institutes of 
Health extends for a three-year period. A 
variety of books and journals are now be-
ing purchased and processed for inclusion 
57 
